2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow PCV20: new trials by email Literature Review of PCV20 trials Research Report on PCV20
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of Age Pn-MAPS30plus, PCV20 - Pneumonia, Bacterial | Phase 1 | Completed | GlaxoSmithKline | 127 | 2025-08-12 | 2026-06-05 |
| Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults 31 valent pneumococcal conjugate vaccine, 20 valent pneumococcal conjugate vaccine - Pneumococcal Vaccines | Phase 1 / Phase 2 | Completed | Vaxcyte, Inc. | 1015 | 2023-11-08 | 2025-07-28 |
GlaxoSmithKline (1) · Vaxcyte, Inc. (1)
Australia (1) · United States (1)